Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

NCT05653531 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no participants enrolled

Conditions

Immune Checkpoint Inhibitor
Lung Cancer
Liver Biomarkers
Transaminases

Interventions

OTHER: Blood sample

Sponsor

Centre Hospitalier Universitaire, Amiens